7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
Identifieur interne : 002843 ( Main/Exploration ); précédent : 002842; suivant : 0028447 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
Auteurs : Ellen M. Ginzler [États-Unis] ; Cynthia Aranow [États-Unis]Source :
- BACR ; 1998.
English descriptors
- KwdEn :
- Teeft :
Abstract
Corticosteroid therapy has had a major impact on improvement in disease activity and long-term survival in patients with systemic lupus erythematosus (SLE). Unfortunately, the therapeutic advantages are accompanied by many manifestations of toxicity, some of which are short term and potentially reversible, while others cause chronic irreversible damage. Many of these features of toxicity have similar presentations to manifestations of SLE disease activity, and must be distinguished in the individual patient. The features of corticosteroid toxicity are reviewed in this chapter, and means of prevention and/or treatment are discussed.
Url:
DOI: 10.1016/S0950-3579(98)80032-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002725
- to stream Istex, to step Curation: 002725
- to stream Istex, to step Checkpoint: 001647
- to stream Main, to step Merge: 002885
- to stream Main, to step Curation: 002843
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus</title><author><name sortKey="Ginzler, Ellen M" sort="Ginzler, Ellen M" uniqKey="Ginzler E" first="Ellen M." last="Ginzler">Ellen M. Ginzler</name></author><author><name sortKey="Aranow, Cynthia" sort="Aranow, Cynthia" uniqKey="Aranow C" first="Cynthia" last="Aranow">Cynthia Aranow</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8C068E5B27046D11D86D66EB2F798C5CC31FD492</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1016/S0950-3579(98)80032-0</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-SXSNPBNR-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002725</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002725</idno><idno type="wicri:Area/Istex/Curation">002725</idno><idno type="wicri:Area/Istex/Checkpoint">001647</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001647</idno><idno type="wicri:Area/Main/Merge">002885</idno><idno type="wicri:Area/Main/Curation">002843</idno><idno type="wicri:Area/Main/Exploration">002843</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus</title><author><name sortKey="Ginzler, Ellen M" sort="Ginzler, Ellen M" uniqKey="Ginzler E" first="Ellen M." last="Ginzler">Ellen M. Ginzler</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Rheumatology Division, State University of New York Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY 11203</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Aranow, Cynthia" sort="Aranow, Cynthia" uniqKey="Aranow C" first="Cynthia" last="Aranow">Cynthia Aranow</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Rheumatology Division, State University of New York Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 42, Brooklyn, NY 11203</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="abbrev">BACR</title><imprint><publisher>ELSEVIER</publisher><date type="published" when="1998">1998</date><biblScope unit="volume">12</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="495">495</biblScope><biblScope unit="page" to="510">510</biblScope></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>avascular necrosis</term><term>corticosteroids</term><term>infection</term><term>osteoporosis</term><term>peptic ulcer disease</term><term>steroid toxicity</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>0ther</term><term>5erum</term><term>5tudy</term><term>5uch</term><term>6een</term><term>6etween</term><term>Act1ve</term><term>Adver5e</term><term>Adver5e effect5</term><term>Amer1can</term><term>Aran0w</term><term>C0nn</term><term>Cataract5</term><term>Decrea5ed</term><term>Effect5</term><term>F0und</term><term>Feature5</term><term>Fr0m</term><term>Lupu5</term><term>M0re</term><term>My0pathy</term><term>Pept1c</term><term>Pept1c u1cer</term><term>Petr1</term><term>Rep0rted</term><term>Rheumat1c</term><term>The5e</term><term>U1cer</term><term>W1th</term><term>Year5</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Corticosteroid therapy has had a major impact on improvement in disease activity and long-term survival in patients with systemic lupus erythematosus (SLE). Unfortunately, the therapeutic advantages are accompanied by many manifestations of toxicity, some of which are short term and potentially reversible, while others cause chronic irreversible damage. Many of these features of toxicity have similar presentations to manifestations of SLE disease activity, and must be distinguished in the individual patient. The features of corticosteroid toxicity are reviewed in this chapter, and means of prevention and/or treatment are discussed.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Ginzler, Ellen M" sort="Ginzler, Ellen M" uniqKey="Ginzler E" first="Ellen M." last="Ginzler">Ellen M. Ginzler</name></region><name sortKey="Aranow, Cynthia" sort="Aranow, Cynthia" uniqKey="Aranow C" first="Cynthia" last="Aranow">Cynthia Aranow</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002843 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002843 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8C068E5B27046D11D86D66EB2F798C5CC31FD492
|texte= 7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus
}}
| This area was generated with Dilib version V0.6.33. |  |